Annual CFI
-$269.78 M
+$890.06 M+76.74%
30 June 2024
Summary:
ResMed annual cash flow from investing activities is currently -$269.78 million, with the most recent change of +$890.06 million (+76.74%) on 30 June 2024. During the last 3 years, it has fallen by -$111.32 million (-70.25%). RMD annual CFI is now -2093.09% below its all-time high of $13.54 million, reached on 30 June 2002.RMD Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$2.15 M
+$48.66 M+104.61%
30 September 2024
Summary:
ResMed quarterly cash flow from investing activities is currently $2.15 million, with the most recent change of +$48.66 million (+104.61%) on 30 September 2024. Over the past year, it has increased by +$151.13 million (+101.44%). RMD quarterly CFI is now -93.65% below its all-time high of $33.77 million, reached on 30 June 2002.RMD Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$118.66 M
+$151.13 M+56.02%
30 September 2024
Summary:
ResMed TTM cash flow from investing activities is currently -$118.66 million, with the most recent change of +$151.13 million (+56.02%) on 30 September 2024. Over the past year, it has increased by +$1.13 billion (+90.51%). RMD TTM CFI is now -360.11% below its all-time high of $45.62 million, reached on 31 December 2002.RMD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMD Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +76.7% | +101.4% | +90.5% |
3 y3 years | -70.3% | +105.1% | +33.4% |
5 y5 years | +74.9% | +106.5% | +87.7% |
RMD Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -70.3% | +76.7% | at high | +100.2% | at high | +90.5% |
5 y | 5 years | -70.3% | +76.7% | at high | +100.2% | -4.3% | +90.5% |
alltime | all time | -2093.1% | +76.7% | -93.7% | +100.2% | -360.1% | +90.5% |
ResMed Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2.15 M(-104.6%) | -$118.66 M(-56.0%) |
June 2024 | -$269.78 M(-76.7%) | -$46.51 M(+40.3%) | -$269.78 M(-0.0%) |
Mar 2024 | - | -$33.15 M(-19.4%) | -$269.80 M(+1.9%) |
Dec 2023 | - | -$41.14 M(-72.4%) | -$264.75 M(-78.8%) |
Sept 2023 | - | -$148.98 M(+220.2%) | -$1.25 B(+7.8%) |
June 2023 | -$1.16 B(+404.5%) | -$46.52 M(+65.5%) | -$1.16 B(-0.7%) |
Mar 2023 | - | -$28.10 M(-97.3%) | -$1.17 B(-1.8%) |
Dec 2022 | - | -$1.03 B(+1645.4%) | -$1.19 B(+382.1%) |
Sept 2022 | - | -$58.81 M(+6.5%) | -$246.85 M(+7.4%) |
June 2022 | -$229.92 M(+45.1%) | -$55.24 M(+11.6%) | -$229.92 M(+3.2%) |
Mar 2022 | - | -$49.49 M(-40.6%) | -$222.75 M(-3.9%) |
Dec 2021 | - | -$83.31 M(+98.9%) | -$231.87 M(+30.1%) |
Sept 2021 | - | -$41.87 M(-12.9%) | -$178.23 M(+12.5%) |
June 2021 | -$158.46 M(-11.9%) | -$48.07 M(-18.0%) | -$158.46 M(+39.2%) |
Mar 2021 | - | -$58.62 M(+97.6%) | -$113.80 M(-26.5%) |
Dec 2020 | - | -$29.66 M(+34.2%) | -$154.79 M(-8.3%) |
Sept 2020 | - | -$22.11 M(+549.0%) | -$168.75 M(-6.2%) |
June 2020 | -$179.86 M(-83.3%) | -$3.41 M(-96.6%) | -$179.86 M(-18.4%) |
Mar 2020 | - | -$99.61 M(+128.4%) | -$220.34 M(-36.3%) |
Dec 2019 | - | -$43.62 M(+31.3%) | -$346.14 M(-64.0%) |
Sept 2019 | - | -$33.22 M(-24.3%) | -$960.74 M(-10.7%) |
June 2019 | -$1.08 B(+956.4%) | -$43.89 M(-80.5%) | -$1.08 B(+0.5%) |
Mar 2019 | - | -$225.41 M(-65.8%) | -$1.07 B(+23.8%) |
Dec 2018 | - | -$658.22 M(+344.2%) | -$864.56 M(+268.5%) |
Sept 2018 | - | -$148.19 M(+284.6%) | -$234.59 M(+130.4%) |
June 2018 | -$101.82 M(+24.3%) | -$38.53 M(+96.4%) | -$101.82 M(+7.7%) |
Mar 2018 | - | -$19.62 M(-30.6%) | -$94.58 M(+1.8%) |
Dec 2017 | - | -$28.25 M(+83.2%) | -$92.88 M(+10.4%) |
Sept 2017 | - | -$15.42 M(-50.7%) | -$84.14 M(+2.8%) |
June 2017 | -$81.89 M(-92.7%) | -$31.28 M(+74.6%) | -$81.89 M(-90.6%) |
Mar 2017 | - | -$17.92 M(-8.2%) | -$868.77 M(-7.0%) |
Dec 2016 | - | -$19.52 M(+48.2%) | -$934.58 M(-13.2%) |
Sept 2016 | - | -$13.17 M(-98.4%) | -$1.08 B(-4.4%) |
June 2016 | -$1.13 B(+686.8%) | -$818.16 M(+877.1%) | -$1.13 B(+240.0%) |
Mar 2016 | - | -$83.73 M(-48.0%) | -$331.07 M(+24.3%) |
Dec 2015 | - | -$161.11 M(+156.8%) | -$266.33 M(+62.2%) |
Sept 2015 | - | -$62.75 M(+167.3%) | -$164.22 M(+14.8%) |
June 2015 | -$143.07 M(+50.6%) | -$23.48 M(+23.6%) | -$143.07 M(+0.4%) |
Mar 2015 | - | -$19.00 M(-67.8%) | -$142.43 M(-2.9%) |
Dec 2014 | - | -$58.99 M(+41.8%) | -$146.63 M(+27.5%) |
Sept 2014 | - | -$41.60 M(+82.2%) | -$115.00 M(+21.1%) |
June 2014 | -$94.99 M(+21.8%) | -$22.84 M(-1.6%) | -$94.99 M(-3.7%) |
Mar 2014 | - | -$23.20 M(-15.2%) | -$98.64 M(+2.3%) |
Dec 2013 | - | -$27.36 M(+26.7%) | -$96.44 M(+14.0%) |
Sept 2013 | - | -$21.59 M(-18.5%) | -$84.61 M(+8.5%) |
June 2013 | -$78.00 M(-23.2%) | -$26.48 M(+26.1%) | -$78.00 M(+30.7%) |
Mar 2013 | - | -$21.00 M(+35.3%) | -$59.67 M(+34.2%) |
Dec 2012 | - | -$15.53 M(+3.6%) | -$44.47 M(-1.0%) |
Sept 2012 | - | -$14.98 M(+83.8%) | -$44.91 M(-55.8%) |
June 2012 | -$101.61 M(+32.8%) | -$8.15 M(+40.3%) | -$101.61 M(-6.4%) |
Mar 2012 | - | -$5.81 M(-63.6%) | -$108.60 M(-7.5%) |
Dec 2011 | - | -$15.97 M(-77.7%) | -$117.39 M(+0.1%) |
Sept 2011 | - | -$71.69 M(+373.6%) | -$117.29 M(+53.3%) |
June 2011 | -$76.51 M(+31.2%) | -$15.14 M(+3.7%) | -$76.51 M(+1.1%) |
Mar 2011 | - | -$14.60 M(-8.0%) | -$75.67 M(+7.4%) |
Dec 2010 | - | -$15.87 M(-48.7%) | -$70.48 M(-7.0%) |
Sept 2010 | - | -$30.91 M(+116.2%) | -$75.82 M(+30.0%) |
June 2010 | -$58.31 M | -$14.30 M(+52.0%) | -$58.31 M(-11.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2010 | - | -$9.41 M(-55.6%) | -$65.67 M(-16.8%) |
Dec 2009 | - | -$21.21 M(+58.3%) | -$78.90 M(-10.1%) |
Sept 2009 | - | -$13.40 M(-38.2%) | -$87.76 M(-19.7%) |
June 2009 | -$109.30 M(+188.7%) | -$21.66 M(-4.3%) | -$109.30 M(+6.6%) |
Mar 2009 | - | -$22.63 M(-24.7%) | -$102.49 M(+49.2%) |
Dec 2008 | - | -$30.07 M(-13.9%) | -$68.70 M(+49.3%) |
Sept 2008 | - | -$34.94 M(+135.3%) | -$46.01 M(+21.6%) |
June 2008 | -$37.85 M(-64.1%) | -$14.85 M(-233.1%) | -$37.85 M(-10.6%) |
Mar 2008 | - | $11.15 M(-251.1%) | -$42.32 M(-38.3%) |
Dec 2007 | - | -$7.38 M(-72.4%) | -$68.59 M(-16.3%) |
Sept 2007 | - | -$26.78 M(+38.6%) | -$81.98 M(-22.2%) |
June 2007 | -$105.42 M(-12.1%) | -$19.31 M(+27.8%) | -$105.42 M(-3.2%) |
Mar 2007 | - | -$15.12 M(-27.2%) | -$108.89 M(-3.4%) |
Dec 2006 | - | -$20.77 M(-58.6%) | -$112.70 M(-7.7%) |
Sept 2006 | - | -$50.21 M(+120.3%) | -$122.08 M(+1.8%) |
June 2006 | -$119.87 M(+38.1%) | -$22.79 M(+20.5%) | -$119.87 M(+5.3%) |
Mar 2006 | - | -$18.92 M(-37.3%) | -$113.81 M(-13.5%) |
Dec 2005 | - | -$30.16 M(-37.2%) | -$131.54 M(-3.1%) |
Sept 2005 | - | -$48.00 M(+187.0%) | -$135.72 M(+56.4%) |
June 2005 | -$86.78 M(+29.8%) | -$16.73 M(-54.4%) | -$86.78 M(+6.9%) |
Mar 2005 | - | -$36.65 M(+6.7%) | -$81.20 M(+20.1%) |
Dec 2004 | - | -$34.34 M(-3749.3%) | -$67.59 M(+98.7%) |
Sept 2004 | - | $941.00 K(-108.4%) | -$34.02 M(-49.1%) |
June 2004 | -$66.84 M(+462.5%) | -$11.15 M(-51.6%) | -$66.84 M(+9.9%) |
Mar 2004 | - | -$23.04 M(+2888.8%) | -$60.82 M(+26.6%) |
Dec 2003 | - | -$771.00 K(-97.6%) | -$48.03 M(+13.5%) |
Sept 2003 | - | -$31.87 M(+520.3%) | -$42.32 M(+256.1%) |
June 2003 | -$11.88 M(-187.8%) | -$5.14 M(-49.9%) | -$11.88 M(-144.0%) |
Mar 2003 | - | -$10.26 M(-307.4%) | $27.03 M(-40.8%) |
Dec 2002 | - | $4.94 M(-444.8%) | $45.62 M(+26.3%) |
Sept 2002 | - | -$1.43 M(-104.2%) | $36.11 M(+166.8%) |
June 2002 | $13.54 M(-109.4%) | $33.77 M(+305.1%) | $13.54 M(-110.7%) |
Mar 2002 | - | $8.34 M(-282.7%) | -$126.56 M(-16.3%) |
Dec 2001 | - | -$4.56 M(-81.0%) | -$151.21 M(+1.4%) |
Sept 2001 | - | -$24.01 M(-77.4%) | -$149.10 M(+3.2%) |
June 2001 | -$144.55 M(+680.3%) | -$106.33 M(+552.0%) | -$144.55 M(+231.8%) |
Mar 2001 | - | -$16.31 M(+562.4%) | -$43.56 M(+39.0%) |
Dec 2000 | - | -$2.46 M(-87.3%) | -$31.34 M(-6.1%) |
Sept 2000 | - | -$19.45 M(+264.2%) | -$33.38 M(+80.2%) |
June 2000 | -$18.52 M(-25.6%) | -$5.34 M(+30.9%) | -$18.52 M(+6.6%) |
Mar 2000 | - | -$4.08 M(-9.3%) | -$17.38 M(-19.5%) |
Dec 1999 | - | -$4.50 M(-2.2%) | -$21.60 M(-15.3%) |
Sept 1999 | - | -$4.60 M(+9.5%) | -$25.50 M(+2.4%) |
June 1999 | -$24.90 M(-8400.0%) | -$4.20 M(-49.4%) | -$24.90 M(+21.5%) |
Mar 1999 | - | -$8.30 M(-1.2%) | -$20.50 M(+107.1%) |
Dec 1998 | - | -$8.40 M(+110.0%) | -$9.90 M(+57.1%) |
Sept 1998 | - | -$4.00 M(-2100.0%) | -$6.30 M(-2200.0%) |
June 1998 | $300.00 K(-105.7%) | $200.00 K(-91.3%) | $300.00 K(-116.7%) |
Mar 1998 | - | $2.30 M(-147.9%) | -$1.80 M(-70.0%) |
Dec 1997 | - | -$4.80 M(-284.6%) | -$6.00 M(+233.3%) |
Sept 1997 | - | $2.60 M(-236.8%) | -$1.80 M(-66.0%) |
June 1997 | -$5.30 M(-15.9%) | -$1.90 M(0.0%) | -$5.30 M(+55.9%) |
Mar 1997 | - | -$1.90 M(+216.7%) | -$3.40 M(+126.7%) |
Dec 1996 | - | -$600.00 K(-33.3%) | -$1.50 M(+66.7%) |
Sept 1996 | - | -$900.00 K | -$900.00 K |
June 1996 | -$6.30 M(-71.7%) | - | - |
June 1995 | -$22.30 M(+4360.0%) | - | - |
June 1994 | -$500.00 K(+150.0%) | - | - |
June 1993 | -$200.00 K | - | - |
FAQ
- What is ResMed annual cash flow from investing activities?
- What is the all time high annual CFI for ResMed?
- What is ResMed annual CFI year-on-year change?
- What is ResMed quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ResMed?
- What is ResMed quarterly CFI year-on-year change?
- What is ResMed TTM cash flow from investing activities?
- What is the all time high TTM CFI for ResMed?
- What is ResMed TTM CFI year-on-year change?
What is ResMed annual cash flow from investing activities?
The current annual CFI of RMD is -$269.78 M
What is the all time high annual CFI for ResMed?
ResMed all-time high annual cash flow from investing activities is $13.54 M
What is ResMed annual CFI year-on-year change?
Over the past year, RMD annual cash flow from investing activities has changed by +$890.06 M (+76.74%)
What is ResMed quarterly cash flow from investing activities?
The current quarterly CFI of RMD is $2.15 M
What is the all time high quarterly CFI for ResMed?
ResMed all-time high quarterly cash flow from investing activities is $33.77 M
What is ResMed quarterly CFI year-on-year change?
Over the past year, RMD quarterly cash flow from investing activities has changed by +$151.13 M (+101.44%)
What is ResMed TTM cash flow from investing activities?
The current TTM CFI of RMD is -$118.66 M
What is the all time high TTM CFI for ResMed?
ResMed all-time high TTM cash flow from investing activities is $45.62 M
What is ResMed TTM CFI year-on-year change?
Over the past year, RMD TTM cash flow from investing activities has changed by +$1.13 B (+90.51%)